Silexion Therapeutics Corp (SLXN)

Silexion Therapeutics Statistics

Total Valuation

SLXN has a market cap or net worth of $1.59 million. The enterprise value is $4.89 million.

Market Cap	1.59M
Enterprise Value	4.89M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

SLXN has 560,974 shares outstanding.

Current Share Class	560,974
Shares Outstanding	560,974
Shares Change (YoY)	n/a
Shares Change (QoQ)	+150.35%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	5.15%
Float	429,724

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.64

Current Ratio	0.64
Quick Ratio	0.34
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-465.59

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-193.54%
Return on Invested Capital (ROIC)	-427.70%
Return on Capital Employed (ROCE)	1,904.70%
Revenue Per Employee	n/a
Profits Per Employee	-$1.17M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SLXN has paid $10,000 in taxes.

Income Tax	10,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.64% in the last 52 weeks. The beta is -0.07, so SLXN's price volatility has been lower than the market average.

Beta (5Y)	-0.07
52-Week Price Change	-92.64%
50-Day Moving Average	3.28
200-Day Moving Average	10.31
Relative Strength Index (RSI)	46.65
Average Volume (20 Days)	67,163

Short Selling Information

The latest short interest is 91,327, so 16.28% of the outstanding shares have been sold short.

Short Interest	91,327
Short Previous Month	145,745
Short % of Shares Out	16.28%
Short % of Float	21.25%
Short Ratio (days to cover)	1.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.57M
Pretax Income	-16.51M
Net Income	-16.44M
EBITDA	-12.55M
EBIT	-12.57M
Earnings Per Share (EPS)	-$395.36

Balance Sheet

The company has $1.19 million in cash and $4.49 million in debt, giving a net cash position of -$3.30 million or -$5.89 per share.

Cash & Cash Equivalents	1.19M
Total Debt	4.49M
Net Cash	-3.30M
Net Cash Per Share	-$5.89
Equity (Book Value)	-3.99M
Book Value Per Share	-32.37
Working Capital	-1.27M

Cash Flow

In the last 12 months, operating cash flow was -$8.40 million and capital expenditures -$22,000, giving a free cash flow of -$8.42 million.

Operating Cash Flow	-8.40M
Capital Expenditures	-22,000
Free Cash Flow	-8.42M
FCF Per Share	-$15.01

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1,035.74%
FCF Yield	-530.25%

Analyst Forecast

The average price target for SLXN is $75.00, which is 2,550.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$75.00
Price Target Difference	2,550.18%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-57.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 29, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Jul 29, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1